BIOFIL CHEMICALS & PHARMACEUTICALS
|
The Current P/S Ratio of BIOFIL CHEMICALS & PHARMACEUTICALS is 2.57.
Share Price | ₹72.6 | Oct 17,2024 |
Market Cap | ₹118.3 Cr | |
Sales-TTM | ₹46.0 Cr | TTM-Standalone Results |
Price/Sales | 2.57x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of BIOFIL CHEMICALS & PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹118.3 Cr] as on Oct 17,2024
(/) Sales [ ₹46.0 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 2.57x ]
Thus, for BIOFIL CHEMICALS & PHARMACEUTICALS , the investors are currently willing to pay '2.57 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BIOFIL CHEMICALS & PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BIOFIL CHEMICALS & PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BIOFIL CHEMICALS & PHARMACEUTICALS
PS Ratio Performance Analysis for BIOFIL CHEMICALS & PHARMACEUTICALS
- BIOFIL CHEMICALS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.46x.
- BIOFIL CHEMICALS & PHARMACEUTICALS 's operated at median p/e ratio of 2.45x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOFIL CHEMICALS & PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 4.2x.
- BIOFIL CHEMICALS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.41x.
How does BIOFIL CHEMICALS & PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
BIOFIL CHEMICALS & PHARMACEUTICALS | 46.0 | 2.57 | 118.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 49,208.8 | 9.22 | 453,486.0 |
CIPLA LTD | 26,139.1 | 4.81 | 125,852.0 |
DR REDDYS LABORATORIES LTD | 28,949.3 | 3.86 | 111,799.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 4.98 | 102,726.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 19.71 | 161,321.0 |
MANKIND PHARMA LTD | 10,649.6 | 10.09 | 107,467.0 |
TORRENT PHARMACEUTICALS LTD | 10,996.0 | 10.45 | 114,943.0 |
LUPIN LTD | 20,797.1 | 4.77 | 99,304.7 |
AUROBINDO PHARMA LTD | 29,718.4 | 2.87 | 85,273.3 |
ABBOTT INDIA LTD | 5,927.5 | 10.19 | 60,382.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BIOFIL CHEMICALS & PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.57x |
Max industry PS | 19.71x |
Median industry PS | 4.98x |
Average industry PS | 7.59x |
You may also like the below Video Courses